Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Mental Health
FDA
Clinical Trials
Biotechnology
Alternative Medicine
General Health
Pharmaceutical
Health
Science
Compass Pathfinder Limited

More Like This

Business Wire logo

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Business Wire logo

Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us